Effect of Contralateral Occlusion on Long-Term Efficacy of Endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS)
Stroke 31:2330-2334, Baker,W.H.,et al, 2000
Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000
Intrathecal Baclofen for the Treatment of Dystonia in Patients with Reflex Sympathetic Dystrophy
NEJM 343:625-630,654, van Hilten,B.J. et al, 2000
Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000
Spinocerebellar Ataxia Type 8
Neurol 55:649-657, Day,J.W. et al, 2000
Long-Term Clinical and Angiographic Outcomes in Symptomatic Patients with 70% to 99% Carotid Artery Stenosis
Stroke 31:2037-2042, Paciaroni,M. et al, 2000
Polymyalgia Rheumatica and Giant Cell Arteritis
Rheum Dis Clin North Amer 26:493-515, Evans,J.M. & Hunder,G.G., 2000
Diffusion-Weighted MR Imaging of the Brain
Radiology 217:331-345, Schaefer,P.W.,et al, 2000
Significance of Surgical Resection for the Treatment of Multiple Brain Metastases
Anticancer Res 20:573-577, Iwadate,Y.,et al, 2000
Neurological Manifestations of Dengue Infection
Lancet 355:1053-1059, Solomon,T.,et al, 2000
Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000
Physical Activity and Risk of Stroke in Women
JAMA 283:2961-2967, Hu,F.B.,et al, 2000
Reversible Tacrolimus-Induced Neurotoxicity Isolated to the Brain Stem
AJNR 21:1251-1254, Oliverio,P.J. et al, 2000
The Acute Behavioral Syndrome of Anterior Thalamic Infarction: A Prospective Study of 12 Cases
Ann Neurol 48:220-227, Chika-Schmid,F. & Bogousslavsky,J., 2000
Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of Stroke
JAMA 284:465-471, Perry,Jr.,H.M. et al, 2000
Adverse Effect of Anticonvulsants on Efficacy of Chemotherapy for Acute Lymphoblastic Leukaemia
Lancet 356:285-290, Relling,M.V. et al, 2000
Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000
Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000
Clinicopath Conf,Cerebral Amyloid Angiogpathy and Giant-Cell Inflammatory Reaction to Beta 4-Amyloid and Vasculitis, Case 10-2000
NEJM 342:957-965, , 2000
Pure Sensory Stroke Caused by a Cerebral Hemorrhage: Clinical-Radiologic Correlations in Seven Patients
AJNR 21:515-520, Shintani,S.,et al, 2000
HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
Frequency of the DYT1 Mutation in Primary Torsion Dystonia Without Family History
ArchNeurol 57:333-335, Brassat,D.,et al, 2000
Neurologic Complications of the Reactivation of Varicella-Zoster Virus
NEJM 342:635-645, Gilden,D.H.,et al, 2000
Pravastatin Therapy and The Risk of Stroke
NEJM 343:317-326, White,H.D. et al, 2000
Acute Posttraumatic Pituitary Gland Hemorrhage
J Comput Assist Tomogr 24:546-547, Vaicys,C. et al, 2000
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000
Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in patients at High Risk of Vascular Disease?
Stroke 31:1779-1784, Hankey,G.J. et al, 2000
C1/C2 Rotary Subluxation Due to Spasmodic Torticollis
JNNP 69:135-136, Dalvie,S. et al, 2000
Whole Grain Consumption and Risk of Ischemic Stroke in Women
JAMA 284:1534-1540, Liu,S. et al, 2000
Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000
New Transient Ischemic Attack and Stroke
Arch Int Med 160:2941-2946, Goldstein,L.B.,et al, 2000
Syndrome of Cerebral Spinal Fluid Hypovolemia
Neurol 55:1321-1327, Chung,S.J.,et al, 2000
Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000
Treatment of Agitation in AD
Neurol 55:1271-1278,1247, Teri,L.,et al, 2000
Visual Manifestations of Giant Cell Arteritis
Medicine 79:283-292, Gonzalez-Gay,M.A.,et al, 2000
Hemidystonia and Hemichoreoathetosis as an Initial Manifestation of Moyamoya Disease
Arch Neurol 57:1510-1512, Lyoo,C.H.,et al, 2000
Carotid Endarterectomy, A Neurotherapeutic Advance
Arch Neurol 57:40-45, Barnett,H.J.M.&Meldrum,H.E., 2000
Multifocal Dural Enhancement Associated with Temporal Arteritis
Arch Neurol 57:119-122, Joelson,E.,et al, 2000
AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000
Physical Activity and Stroke Mortality in Women, Ten-Year Follow-Up of the Nord-Trondelag Health Survey, 1984-1986
Stroke 31:14-18, Ellekjaer,H.,et al, 2000
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000
Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000
The Nonmotor Problems of Parkinson's Disease
The Neurologist 6:18-27, Friedman,J.H.&Fernandez,H.H., 2000
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
NEJM 342:1773-1777,1824, Bennett,C.L.,et al, 2000
Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000
North Carolina Stroke Prevention and Treatment Facilities Survey
Stroke 31:66-70, Goldstein,L.B.,et al, 2000
Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000